Back to Search
LAURA TYSON, PHARMD
PHARMD
Pharmacist
NPI: 1013005057Individual
Specialties, Licenses & Credentials
Research & Publications (14)
Putting evidence into practice: evidence-based interventions for cancer-related dyspnea.
PMID 18390468·Clin J Oncol Nurs·2008
6-review
Non-small cell lung cancer: new hope for a chronic illness.
PMID 17878125·Oncol Nurs Forum·2007
6-review
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus.
PMID 17785570·Clin Cancer Res·2007
8-other
A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer.
PMID 17607120·J Thorac Oncol·2007
3-trial
A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.
PMID 17473201·Clin Cancer Res·2007
3-trial
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.
PMID 16208701·Cancer·2005
3-trial
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
PMID 15812822·Cancer·2005
3-trial
Practical management of patients with non-small-cell lung cancer treated with gefitinib.
PMID 15557594·J Clin Oncol·2005
8-other
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
PMID 15447995·Clin Cancer Res·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 N DAVIS ST
NASHVILLE, GA 31639 - Phone
- (229) 316-8200
Quick Facts
- NPI
- 1013005057
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile